Mary Theresa Coelho - 12 Jun 2023 Form 4 Insider Report for Gamida Cell Ltd.

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
14 Jun 2023, 16:21:24 UTC
Prior SEC filing
09 Jun 2023
Next SEC filing
18 Oct 2023
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Joshua F. Patterson, Attorney-in-Fact

Key filing fact

Mary Theresa Coelho filed Form 4 for Gamida Cell Ltd. on 14 Jun 2023.

Key facts

  • This page summarizes Mary Theresa Coelho's Form 4 filing for Gamida Cell Ltd..
  • 1 reported transaction and 1 derivative row are listed below.
  • Accepted by SEC: 14 Jun 2023, 16:21.

Change

  • Previous filing in this sequence was filed on 09 Jun 2023.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

GMDA transaction Derivative

Share Option (Right to Buy)

Award

Transaction value
$0
Shares
+10,000
Change %
Price
$0.000000
Shares after
10,000
Date
12 Jun 2023
Ownership
Direct
Underlying class
Ordinary Shares
Underlying amount
10,000
Exercise price
$1.98
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

This option vests on the earlier of (i) the date of the closing of a Merger/Sale (as such term is defined under the Issuer's 2017 Share Incentive Plan (as amended)), or (ii) May 22, 2024, so long as, prior to such date, (x) the Reporting Person has not terminated without cause the Reporting Person's Consulting Agreement (the "Agreement") with the Issuer or (y) the Issuer has not terminated the Agreement for breach (and such breach has not been cured).

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .